Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Treasury Shares (2020 - 2023)

Historic Treasury Shares for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $85.6 million.

  • Cullinan Therapeutics' Treasury Shares changed N/A to $85.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $85.6 million, marking a year-over-year change of. This contributed to the annual value of $369000.0 for FY2022, which is 41450674.16% up from last year.
  • According to the latest figures from Q3 2023, Cullinan Therapeutics' Treasury Shares is $85.6 million.
  • Cullinan Therapeutics' Treasury Shares' 5-year high stood at $85.6 million during Q2 2023, with a 5-year trough of $89.0 in Q4 2021.
  • For the 4-year period, Cullinan Therapeutics' Treasury Shares averaged around $34.4 million, with its median value being $369000.0 (2022).
  • Per our database at Business Quant, Cullinan Therapeutics' Treasury Shares tumbled by 9997.55% in 2021 and then skyrocketed by 41450674.16% in 2022.
  • Cullinan Therapeutics' Treasury Shares (Quarter) stood at $364000.0 in 2020, then plummeted by 99.98% to $89.0 in 2021, then soared by 414506.74% to $369000.0 in 2022, then surged by 23097.83% to $85.6 million in 2023.
  • Its last three reported values are $85.6 million in Q3 2023, $85.6 million for Q2 2023, and $369000.0 during Q4 2022.